12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12只医疗保健股票在周三盘前交易中有所波动
Gainers
赢家
- Mersana Therapeutics (NASDAQ:MRSN) shares rose 22.7% to $2.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $331.2 million. As per the news, the Q3 earnings report came out today.
- Kairos Pharma (AMEX:KAPA) stock rose 19.74% to $2.46. The market value of their outstanding shares is at $31.5 million.
- Calidi Biotherapeutics (AMEX:CLDI) shares increased by 18.48% to $2.5. The market value of their outstanding shares is at $29.1 million. The company's, Q3 earnings came out yesterday.
- Natera (NASDAQ:NTRA) shares rose 16.66% to $157.64. The company's market cap stands at $19.4 billion. As per the news, the Q3 earnings report came out yesterday.
- Ensysce Biosciences (NASDAQ:ENSC) stock increased by 15.62% to $0.78. The market value of their outstanding shares is at $11.6 million. The company's, Q3 earnings came out yesterday.
- Lexeo Therapeutics (NASDAQ:LXEO) stock increased by 12.61% to $8.66. The company's market cap stands at $286.3 million. The company's, Q3 earnings came out today.
- 在周三的盘前交易中,Mersana Therapeutics(纳斯达克股票代码:MRSN)股价上涨22.7%,至2.7美元。他们已发行股票的市值为3.312亿美元。根据新闻,第三季度收益报告今天发布。
- Kairos Pharma(美国证券交易所股票代码:KAPA)股价上涨19.74%,至2.46美元。他们已发行股票的市值为3,150万美元。
- Calidi Biotherapeutics(美国证券交易所股票代码:CLDI)股价上涨18.48%,至2.5美元。他们已发行股票的市值为2910万美元。该公司昨天公布了第三季度的收益。
- 纳泰拉(纳斯达克股票代码:NTRA)股价上涨16.66%,至157.64美元。该公司的市值为194亿美元。根据新闻,第三季度收益报告于昨天发布。
- Ensysce Biosciences(纳斯达克股票代码:ENSC)股价上涨15.62%,至0.78美元。他们已发行股票的市值为1160万美元。该公司昨天公布了第三季度的收益。
- Lexeo Therapeutics(纳斯达克股票代码:LXEO)股价上涨12.61%,至8.66美元。该公司的市值为2.863亿美元。该公司今天公布了第三季度的收益。
Losers
失败者
- Syros Pharmaceuticals (NASDAQ:SYRS) shares decreased by 85.6% to $0.39 during Wednesday's pre-market session. The market value of their outstanding shares is at $10.5 million.
- GlucoTrack (NASDAQ:GCTK) stock decreased by 72.24% to $0.44. The market value of their outstanding shares is at $2.5 million.
- Psyence Biomedical (NASDAQ:PBM) stock fell 23.4% to $0.05. The company's market cap stands at $2.9 million.
- CERo Therapeutics Hldgs (NASDAQ:CERO) shares declined by 20.03% to $0.21. The market value of their outstanding shares is at $32.1 million.
- Geovax Labs (NASDAQ:GOVX) shares declined by 20.0% to $2.6. The company's market cap stands at $22.1 million. As per the press release, Q3 earnings came out yesterday.
- Virpax Pharmaceuticals (NASDAQ:VRPX) shares fell 17.6% to $0.51. The market value of their outstanding shares is at $2.4 million.
- 锡罗斯制药公司(纳斯达克股票代码:SYRS)股价在周三的盘前交易中下跌了85.6%,至0.39美元。他们已发行股票的市值为1,050万美元。
- GlucoTrack(纳斯达克股票代码:GCTK)股价下跌72.24%,至0.44美元。他们已发行股票的市值为250万美元。
- Psyence Biomedical(纳斯达克股票代码:PBM)股票下跌23.4%,至0.05美元。该公司的市值为290万美元。
- CerO Therapeutics Hldgs(纳斯达克股票代码:CERO)股价下跌20.03%,至0.21美元。他们已发行股票的市值为3,210万美元。
- Geovax Labs(纳斯达克股票代码:GOVX)股价下跌20.0%,至2.6美元。该公司的市值为2210万美元。根据新闻稿,第三季度财报于昨天公布。
- Virpax 制药公司(纳斯达克股票代码:VRPX)股价下跌17.6%,至0.51美元。他们已发行股票的市值为240万美元。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动化内容引擎生成,并由编辑审阅。